Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
K.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.73EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEBEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XEBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.263EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.74 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.74 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621.1 (Mu)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.621.1 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
BF.7.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
BF.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.67EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
BQ.1.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
CK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
BE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.16.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.72EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.517EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.291EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.291EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.349EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used